Management of hyperglycemia in the pediatric intensive care unit; implementation of a glucose control protocol

Jennifer J Verhoeven1, Jeannette B Brand, Mirjam M van de Polder

  • 1Intensive Care, Erasmus MC-Sophia Children's Hospital Rotterdam, Rotterdam, The Netherlands.

Insights

A nurse-driven protocol effectively managed hyperglycemia in critically ill children, achieving normal blood glucose levels in 94% within 12 hours without severe hypoglycemia. This glucose control strategy shows promise for pediatric intensive care units.

Area of Science:

  • Pediatric Critical Care Medicine
  • Endocrinology
  • Nursing Practice

Background:

  • Hyperglycemia is common in critically ill children and associated with adverse outcomes.
  • Effective glucose control is crucial for improving patient outcomes in pediatric intensive care units (PICUs).
  • Existing protocols may require refinement for optimal implementation in pediatric populations.

Purpose of the Study:

  • To evaluate the efficacy and safety of a stepwise nurse-driven glucose control protocol.
  • To assess the time to achieve normoglycemia in critically ill pediatric patients with hyperglycemia.
  • To determine the incidence of severe hypoglycemia during protocol implementation.

Main Methods:

  • Prospective observational study conducted in an academic pediatric intensive care unit.
  • Inclusion of 50 consecutively admitted critically ill children with hyperglycemia (>8 mmol/L).
  • Treatment administered according to a stepwise nurse-driven glucose control protocol.

Main Results:

  • The protocol achieved normoglycemia (<8 mmol/L) in 94% (47/50) of children within a median of 5 hours after insulin initiation.
  • Insulin therapy was initiated at a median blood glucose of 11.4 mmol/L, 4 hours after documented hyperglycemia.
  • No episodes of severe hypoglycemia (<2.2 mmol/L) were observed during the study period.

Conclusions:

  • The nurse-driven glucose control protocol is effective in normalizing blood glucose levels in critically ill children.
  • The protocol demonstrated a favorable safety profile, with no severe hypoglycemia events.
  • Further research is warranted to confirm safety and facilitate broader implementation in PICUs.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...